MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-27-0024540
Epygen Biotech Private Limited - chemicals and materials in Rasayani, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹23.61 Cr
▲ 138% YoY
Net profit · FY 2025
₹7.02 Cr
Net margin 29.7%
EBITDA · FY 2025
₹14.59 Cr
EBITDA margin 61.8%
Authorised capital
₹19.55 Cr
Registered with MCA
Paid-up capital
₹14.96 Cr
Issued & subscribed
Open charges
₹39.56 Cr
Secured borrowings
Company age
15 yrs
Est. 2011
Employees · EPFO
47
Provident fund records
About Epygen Biotech Private Limited
Data last updated:
Epygen Biotech Private Limited is a private limited company based in Rasayani, Maharashtra, India. It operates in the industrial enzymes and biochemicals segment of the chemicals and materials sector. It was incorporated on 25 August 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2011PTC221254. Its GSTIN is 27AACCE8299C1ZF (Maharashtra).
The company has an authorised share capital of ₹19.55 Cr and a paid-up capital of ₹14.96 Cr. It is led by directors including Debayan Sukhamoy Ghosh and Ineeyan Vivekanandan Ariyaratnam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. N – 28/2 Additional MIDC Patalganga Taluka – Panvel, Rasayani, Maharashtra, India – 410220.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.61 Cr, a growth of 138% compared to the previous year. For the same year it recorded a net profit of ₹7.02 Cr (net margin 29.7%) and EBITDA of ₹14.59 Cr (EBITDA margin 61.8%). Revenue has grown at a compounded annual rate (CAGR) of 106% over three years and 62% over five years.
The company has about 47 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Epygen Biotech and Epygen. As per MCA filings, the company has open charges of ₹39.56 Cr on record. The company has 7 deals on record (5 funding rounds, 2 secondary share transfers), with disclosed funding of ₹19.57 Cr; the latest was in December 2019. Its 4 peer companies in the Chemicals industry (Contract Research, Enzymes), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 1 smaller; the largest is Remidex Pharma Private Limited with revenue of ₹24.56 Cr.
Epygen Biotech Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-27-0024540). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website epygenbiotech.com.
Company details
CIN U24233MH2011PTC221254
Registration Number 221254
Incorporation Date 25 August 2011
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-27-0024540
Key People
Debayan Sukhamoy Ghosh Director Ineeyan Vivekanandan Ariyaratnam Director Soumitro Deb Director Recognitions & Rankings of Epygen Biotech
Contact details
Epygen Biotech Private Limited's registered office is in Rasayani, Maharashtra. Its website is epygenbiotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. N – 28/2 Additional MIDC Patalganga Taluka – Panvel, Rasayani, Maharashtra, India – 410220
- IndustryChemicals and Materials, Industrial Enzymes & Biochemicals
To see the full contact details of Epygen Biotech Private Limited, buy the company report.
Comprehensive company report
Epygen Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Epygen Biotech operates two associated brands: Epygen Biotech and Epygen. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Therapeutic proteins for oncology and cardiovascular disorders are developed. | epygenbiotech.com | |
| Enzymes for therapeutic and industrial applications are researched and manufactured. | epygen.com |
Business activity
The main business activity of Epygen Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Epygen Biotech Private Limited, buy the company report.
Financials of Epygen Biotech Private Limited
FY 2025 filings availableEpygen Biotech Private Limited reported revenue of ₹23.61 Cr (up 138% YoY) for FY 2025.
Revenue · FY 2025
₹23.61 Cr ▲ 138%
Net profit · FY 2025
₹7.02 Cr margin 29.7%
EBITDA · FY 2025
₹14.59 Cr margin 61.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 138%
3 years · compounded
▲ 106%
5 years · compounded
▲ 62%
EBITDA CAGR growth
1 year
▲ 164%
3 years · compounded
▲ 128%
5 years · compounded
▲ 103%
Revenue has grown at a compounded annual rate (CAGR) of 62% over five years, including 138% growth in the latest year. EBITDA rose 164% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.59 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.02 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 61.8% | ||||
| Net Profit Margin | 29.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Epygen Biotech Private Limited, buy the company report.
Board of directors of Epygen Biotech Private Limited
Epygen Biotech has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Debayan Sukhamoy Ghosh Also directs: Genores Biotech Private Limited | Director | 25 Aug 2011 | 15 Years 2 Months | Current |
| Ineeyan Vivekanandan Ariyaratnam | Director | 25 Aug 2011 | 15 Years 2 Months | Current |
| Soumitro Deb Also directs: Genores Biotech Private Limited | Director | 18 Mar 2020 | 6 Years 7 Months | Current |
| Manickam Also directs: Genores Biotech Private Limited | Director | 11 Jul 2016 | 10 Years 3 Months | Current |
Peer comparison
Epygen Biotech Private Limited is compared with the 4 companies closest to it by revenue in the Chemicals industry (Contract Research, Enzymes), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Remidex Pharma Private Limited | ₹24.56 Cr (FY 2025) | -22.0% | Bengaluru, Karnataka, India | |||
| Sunvij Drugs Private Limited | ₹24.23 Cr (FY 2024) | 24.0% | Vadodara, Gujarat, India | |||
| Lyra Laboratories Private Limited | ₹24.06 Cr (FY 2025) | 1.0% | Buranwala, Himachal Pradesh, India | |||
| Epygen Biotech Private Limitedthis company | ₹23.61 Cr (FY 2025) | ₹7.02 Cr | 29.7% | 138.0% | 47 | Rasayani, Maharashtra, India |
| Shobha Life Sciences Private Limited | ₹23.2 Cr (FY 2025) | 467.0% | Secunderabad, Telangana, India |
To see the full peer comparison of Epygen Biotech Private Limited, buy the company report.
Auditor
Epygen Biotech Private Limited is audited by D. Kothary & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D. Kothary & Co. | FY 2023 | 105335W |
Shareholding
The shareholding of Epygen Biotech Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Epygen Biotech Private Limited, buy the company report.
Charges & borrowings
Open charges
₹39.56 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Sep 2018 | 100219906 | Others | ₹11.78 Cr | Open | |
| 29 Sep 2016 | 100055184 | Others | ₹27.78 Cr | Open |
To see the full charge records of Epygen Biotech Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Epygen Biotech Private Limited has 7 deals on record (5 funding rounds, 2 secondary share transfers), with disclosed funding of ₹19.57 Cr; the latest was in December 2019.
Total deals
7
Funding rounds
5
Secondary share transfers
2
Disclosed funding
₹19.57 Cr
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2019 | Funding round | ₹27.4 Lakh | Investors: 4 individuals |
| Jan 2018 | Secondary share transfer | Undisclosed | Seller: Scigenics (India) Private Limited |
| Oct 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Sep 2016 | Funding round | ₹7.06 Cr | Investors: 4 individuals |
| Jan 2015 | Funding round | ₹2.48 Cr | Investors: 2 individuals |
To see the full deal history of Epygen Biotech Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Epygen Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
Credit ratings & regulatory alerts
Epygen Biotech Private Limited was last rated by Crisil on 22 Jun 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 22 Jun 2020 |
To see the full credit ratings and regulatory alerts of Epygen Biotech Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Epygen Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Epygen Biotech Private Limited has a workforce of 47 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
47
Active EPFO establishments
1
Employee growth
6.82%
GST
Epygen Biotech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCE8299C1ZF | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Epygen Biotech Private Limited, buy the company report.
Recent activity
Epygen Biotech Private Limited has 7 board changes on record since 2011: 4 appointments and 3 cessations. The latest: Soumitro Deb ceased to be Additional Director on 31 Dec 2020.
AGM
Epygen Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Epygen Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others of Rs. 27.78 Cr registered on 29 Sep 2016 with Charge ID 100055184 was modified on 22 Jun 2021.
Ceased
Soumitro Deb ceased to be Additional Director.
Appointed
Soumitro Deb was appointed as Director.
Ceased
Sukhamoy Ghosh ceased to be Director.
Charges
A charge with Others amounted to Rs. 11.78 Cr with Charge ID 100219906 was registered on 07 Sep 2018.
Ceased
Manickam ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 27.78 Cr with Charge ID 100055184 was registered on 29 Sep 2016.
Appointed
Manickam was appointed as Director.
Appointed
Debayan Sukhamoy Ghosh was appointed as Director.
Appointed
Ineeyan Vivekanandan Ariyaratnam was appointed as Director.
1 earlier event is in the company report.
News
Frequently asked questions
Epygen Biotech is an active private limited company based in Rasayani, Maharashtra, India. The company works in industrial enzymes and biochemicals, within the chemicals and materials industry. It was incorporated on 25 August 2011 (15+ years old) and is registered under CIN U24233MH2011PTC221254.
Epygen Biotech has 4 current directors:
- Debayan Sukhamoy Ghosh - Director
- Ineeyan Vivekanandan Ariyaratnam - Director
- Soumitro Deb - Director
- Manickam - Director
The latest financial statements of Epygen Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Epygen Biotech is 27AACCE8299C1ZF, registered in Maharashtra.
The CIN (Corporate Identification Number) of Epygen Biotech is U24233MH2011PTC221254. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Epygen Biotech was incorporated on 25 August 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
Epygen Biotech has 7 deals on record (5 funding rounds, 2 secondary share transfers), with disclosed funding of ₹19.57 Cr; the latest was in December 2019.
The peers of Epygen Biotech by revenue are Remidex Pharma Private Limited, Sunvij Drugs Private Limited, Lyra Laboratories Private Limited, Shobha Life Sciences Private Limited, all in the Chemicals industry (Contract Research, Enzymes), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Soumitro Deb ceased to be Additional Director on 31 Dec 2020. Soumitro Deb was appointed as Director on 18 Mar 2020. Sukhamoy Ghosh ceased to be Director on 18 Mar 2020. Epygen Biotech has 7 board changes on record in total.
Yes, Epygen Biotech is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-27-0024540).
Epygen Biotech can be reached through the website epygenbiotech.com. Its registered office is in Rasayani, Maharashtra, India.